Rosemary Ffrench

2.1k total citations
43 papers, 1.5k citations indexed

About

Rosemary Ffrench is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Rosemary Ffrench has authored 43 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 18 papers in Immunology and 18 papers in Hepatology. Recurrent topics in Rosemary Ffrench's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (13 papers) and Immune Cell Function and Interaction (11 papers). Rosemary Ffrench is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (13 papers) and Immune Cell Function and Interaction (11 papers). Rosemary Ffrench collaborates with scholars based in Australia, United States and United Kingdom. Rosemary Ffrench's co-authors include Andrew R. Lloyd, George Marinos, Anthony Freeman, Jeffrey J. Post, William D. Rawlinson, Charles Harvey, Patricia Palladinetti, Peter A. White, Rakesh Kumar and John Kaldor and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Rosemary Ffrench

42 papers receiving 1.4k citations

Peers

Rosemary Ffrench
Thomas Kuntzen United States
Stewart Cooper United States
Deborah Marcus-Bagley United States
V. Faber Denmark
G. L. Toms United Kingdom
Harvey J. Alter United States
Rosemary Ffrench
Citations per year, relative to Rosemary Ffrench Rosemary Ffrench (= 1×) peers Susan McKiernan

Countries citing papers authored by Rosemary Ffrench

Since Specialization
Citations

This map shows the geographic impact of Rosemary Ffrench's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemary Ffrench with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemary Ffrench more than expected).

Fields of papers citing papers by Rosemary Ffrench

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemary Ffrench. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemary Ffrench. The network helps show where Rosemary Ffrench may publish in the future.

Co-authorship network of co-authors of Rosemary Ffrench

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemary Ffrench. A scholar is included among the top collaborators of Rosemary Ffrench based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemary Ffrench. Rosemary Ffrench is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bundell, Christine, E. McKinnon, Margaret Hellard, et al.. (2020). Frequent occurrence of low-level positive autoantibodies in chronic hepatitis C. Pathology. 52(5). 576–583. 3 indexed citations
2.
Gill, Paul A., Menno C. van Zelm, Rosemary Ffrench, Jane G. Muir, & Peter R. Gibson. (2019). Successful elevation of circulating acetate and propionate by dietary modulation does not alter T-regulatory cell or cytokine profiles in healthy humans: a pilot study. European Journal of Nutrition. 59(6). 2651–2661. 23 indexed citations
3.
Ffrench, Rosemary, Maya Korem, David J. Curtis, et al.. (2018). Contemporary analysis of functional immune recovery to opportunistic and vaccine‐preventable infections after allogeneic haemopoietic stem cell transplantation. Clinical & Translational Immunology. 7(10). e1040–e1040. 4 indexed citations
4.
Flynn, Jacqueline K., Gregory J. Dore, Margaret Hellard, et al.. (2013). Maintenance of Th1 hepatitis C virus (HCV)‐specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment. Journal of Gastroenterology and Hepatology. 28(11). 1770–1781. 17 indexed citations
5.
Flynn, Jacqueline K., Gregory J. Dore, Gail Matthews, et al.. (2012). Impaired Hepatitis C Virus (HCV)–Specific Interferon-γ Responses in Individuals With HIV Who Acquire HCV Infection: Correlation With CD4+ T-Cell Counts. The Journal of Infectious Diseases. 206(10). 1568–1576. 19 indexed citations
6.
Flynn, Jacqueline K., Gregory J. Dore, Margaret Hellard, et al.. (2010). Early IL-10 predominant responses are associated with progression to chronic hepatitis C virus infection in injecting drug users. Journal of Viral Hepatitis. 18(8). 549–561. 51 indexed citations
7.
Gowans, Eric J., Stuart K. Roberts, Kathryn Jones, et al.. (2010). A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals. Journal of Hepatology. 53(4). 599–607. 49 indexed citations
8.
Ffrench, Rosemary, et al.. (2010). Clearance of hepatitis C virus and T cell response in a child with anti‐liver kidney microsomal‐1 antibodies treated with steroids. Journal of Paediatrics and Child Health. 47(6). 389–391.
10.
Thomson, Scott, Charani Ranasinghe, Stephen J. Kent, et al.. (2005). Development of a synthetic consensus sequence scrambled antigen HIV-1 vaccine designed for global use. Vaccine. 23(38). 4647–4657. 26 indexed citations
11.
Freeman, Anthony, George Marinos, Rosemary Ffrench, & Andrew R. Lloyd. (2005). Intrahepatic and peripheral blood virus‐specific cytotoxic T lymphocyte activity is associated with a response to combination IFN‐α and ribavirin treatment among patients with chronic hepatitis C virus infection*. Journal of Viral Hepatitis. 12(2). 125–129. 12 indexed citations
12.
Dale, C. Jane, Robert De Rose, Keith T. Wilson, et al.. (2004). Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12. Vaccine. 23(2). 188–197. 44 indexed citations
13.
Ffrench, Rosemary, et al.. (2004). Polymorphism report: identification of two common single nucleotide polymorphisms in the human toll-like receptor 5 (TLR5) gene. Molecular and Cellular Probes. 18(3). 205–205. 2 indexed citations
14.
Ffrench, Rosemary, et al.. (2003). Transmembrane T‐cell receptor peptides inhibit B‐ and natural killer‐cell function. Immunology. 108(4). 458–464. 16 indexed citations
15.
Freeman, Anthony, Yong Pan, Charles Harvey, et al.. (2003). The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection. Journal of Hepatology. 38(3). 349–356. 57 indexed citations
16.
Agnew, Linda L., Mark Kelly, Jonathan Howard, et al.. (2003). Altered lymphocyte heat shock protein 70 expression in patients with HIV disease. AIDS. 17(13). 1985–1988. 17 indexed citations
17.
Ffrench, Rosemary, et al.. (2001). In Vitro HIV-Specific CTL Activity from HIV-Seropositive Individuals Is Augmented by Interleukin-12 (IL-12). AIDS Research and Human Retroviruses. 17(3). 233–242. 7 indexed citations
18.
Tangye, Stuart G., et al.. (2001). Reduced memory B‐cell populations in boys with B‐cell dysfunction after bone marrow transplantation for X‐linked severe combined immunodeficiency. British Journal of Haematology. 112(4). 1004–1011. 8 indexed citations
19.
Woodberry, Tonia, Joshua Gardner, Lani R. San Mateo, et al.. (1999). Immunogenicity of an HIV polytope vaccine containing multiple HLA-A2 HIV CD8+ cytotoxic T cell epitopes. Journal of Virology. 1 indexed citations
20.
Lindeman, Robert W., et al.. (1998). Carrier identification in X‐linked immunodeficiency diseases. Journal of Paediatrics and Child Health. 34(3). 273–279. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026